Reference Interval Validation of High-Sensitivity Cardiac Troponin T Assay in Thai Population
NCT ID: NCT03968016
Last Updated: 2019-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2019-01-27
2019-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on High-sensitivity Troponin 0h/1h for Rapid Diagnosis of Non-ST-segment Elevation Myocardial Infarction in the Chinese Population
NCT03331549
Healthy Adult Reference Biobank for Cardiovascular Biomarkers in China
NCT07136675
Hs-cTnI Diagnosis of NSTE-ACS Patients in China
NCT03734796
Age Gender Left Ventricular Mass and Cardiac Troponin T
NCT01100710
Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction
NCT04280926
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy
Control group
SYSMEX HLSCL
Diagnostic device
Stable heart disease
Stable heart disease and non-hospitalized
SYSMEX HLSCL
Diagnostic device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SYSMEX HLSCL
Diagnostic device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Group 2: Aged \> 40 - 70 years
* A presumably healthy population will define from a health questionnaire
* Aged \> 40 - 70 years
* Stable heart disease individuals will be evaluated by cardiologist
* Non hospitalized (OPD settings)
Exclusion Criteria
* Renal diseases (CKD or recent AKI)
* History of pulmonary embolism
For Patient group with stable heart diseases
* Stable heart diseases with ACS
* Renal diseases (CKD or recent AKI)
* History of pulmonary embolism
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chulalongkorn University
Pathum Wan, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Troponin T
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.